Drug Evaluation Data

Verbist L. Gyselen A. : Antituberculous activity of Rifampicin In Vitro and in Vivo and the Concentrations Attained in Human Blood?, Amer. Rev. Resp. Dis. 98: 923–932 (Dec.) 1968.

Goodman L. S. Gilman A. (editors): The Pharmacological Basis of Therapeutics, ed. 4, The MacMillan Company, New York, 1970, p. 1333–1334.

Hobby G. L. Lenert T. F. : The Action of Rifampin Alone and In Combination with Other Antituberculosis Drugs?, Amer. Rev. Resp. Dis. 102: 462–465 (Sept.) 1970.

Dans P.E. : Rifampin: Antibacterial Activity In Vitro and Absorption and Excretion in Normal Young Men?, Amer. J. Med. Sci. 259: 120–132 (Feb.) 1970.

Vall-Spinosa A. : Rifampin in the Treatment of Drug-Resistant Mycobacterium Tuberculosis Infections?, New Engl. J. Med. 283: 616–621 (Sept. 17) 1970.

Anon.: Rifadin (Rifampin): Introducing a New Era in the Treatment of Pulmonary Tuberculosis (A product information booklet prepared by Dow Chemical Co.) 1971.

Hobby G. S. Johnson P. M. Boytar-Papirnyik V. : Primary Drug Resistance: A Continuing Study of Drug Resistance in Tuberculosis in a Veteran Population within the United States?, Amer. Rev. Resp. Dis. 102: 347–355 (Sept.) 1970.

Viswanathan R. : Controlled Clinical Trial with Rimactane in Fresh, Untreated cases of Pulmonary Tuberculosis?, Indian J. Med. Res. 58: 519–524 (Apr.) 1970.

Devine L. F. : Rifampin: Effect of Two-day Treatment on the Meningococcal Carrier State and the Relationship to the Levels of Drug in Sera and Saliva?, Amer. J. Med. Sci. 261: 79–83 (Feb.) 1971.

Newman R. : Rifampin in Initial Treatment of Pulmonary Tuberculosis?, Amer. Rev. Resp. Dis. 103: 461–476 (Mar.) 1971.

Dormer B. A. : Comparative Controlled Trial of Rimactane in Pulmonary Tuberculosis?, Int. J. Clin. Pharm. 2: 188 (Apr.) 1969.

Bergamini N. : Rifampicin: A Clinical Survey?, Arzneimittel-Forsch. 20: 1546–1551 (Oct.) 1970.

Poole G. Stradling P. Worlledge S. : Potentially Serious Side Effects of Highdose Twice-Weekly Rifampicin?, Brit. Med. J. 3: 343–347 (Aug. 7) 1971.

Atlas E. Turck M. : Laboratory and Clinical Evaluation of Rifampicin?, Amer. J. Med. Sci. 256: 247–254 (Oct.) 1968.

Bowman G. : Drug Interaction: Decreased Serum Concentrations of Rifampin When Given with PAS (Communication)?, Lancet 1: 800 (Apr. 17) 1971.

Visconti J. A. : PAS Influence on the Absorption of Rifampicin, The White Sheet (A publication of Philips Roxane Laboratories, Inc.) 1971.

Loudon H. Prasad J. : Tolerance of Rifampicin?, Brit. Med. J. 2: 51 (Apr. 4) 1970.